Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Diabetes Drug Inhibits Cancer Growth
Clinical Breakthroughs

Diabetes Drug Inhibits Cancer Growth

By Sarah PlumridgeJul 24, 2014
Share
Facebook Twitter Email
Navdeep S. Chandel, PhD, professor in Medicine-Pulmonary and Cell and Molecular Biology, and collaborators show that metformin inhibits mitochondrial complex I in human cancer cells to reduce tumor burden. 

 

Northwestern Medicine scientists have demonstrated how metformin, a drug widely used to treat patients with type II diabetes, inhibits cancer progression.

Recent studies suggest that the anti-diabetic drug prevents cancer progression, but how metformin diminishes tumor growth is not fully understood.

Metformin works by decreasing insulin in the blood. It is postulated that since cancer cells need insulin to multiply, the drug slows down tumor growth by cutting the energy supply produced by their mitochondria.

Navdeep S. Chandel, PhD, professor in Medicine-Pulmonary and Cell and Molecular Biology, and collaborators showed that metformin inhibits the function of mitochondrial complex I in human cancer cells, which reduces tumor burden. Mitochondrial complex I is a compound central to energy production in the cell.

First authors are William W. Wheaton, graduate student in Walter S. and Lucienne Driskill Graduate Training Program in Life Sciences, and Samuel E. Weinberg, MD/PhD student in the Medical Scientist Training Program. The paper was published May 13 in eLife.

They studied the effects of metformin on cancer cells by using tissue cultures to measure oxygen consumption and mouse models to observe tumor growth.

The team discovered that when glucose is abundant, metformin slows down the rate of cancer cell division, but when cells are deprived of glucose, metformin kills the cancer cells.

The researchers also found that metformin inhibits the pathways that regulate a system that helps cells to survive low-oxygen conditions.

“Our study shows that metformin inhibits mitochondrial complex I to diminish the tumor burden,” said Chandel. “We suggest that metformin may stop tumor progression more effectively when used alongside other therapies that reduce the availability of both oxygen and glucose inside cells.

“In this paper we’ve shown in cancer models that metformin acts through mitochondrial complex I,” Chandel said. “The question is, as people have shown the anti-diabetic, anti-inflammatory and anti-aging effects of this drug in mice, whether all of those effects are also due to metformin’s interaction with mitochondrial complex I. We now have a tool where we can go in and ask these questions and it sets a precedent to conducting these experiments in the future.”

Chandel also plans to continue studying how metformin works when administered with other cancer therapies.

The study was funded by National Institutes of Health grants RO1CA123067, T32GM08061, and T32HL076139.

Cancer Research
Share. Facebook Twitter Email

Related Posts

Investigating the Connection Between Steps and Heart Disease Risk

Feb 1, 2023

Transforming the Way Cancer Vaccines are Designed and Made

Jan 30, 2023

Calcium Channels Regulate Neuroinflammation and Neuropathic Pain 

Jan 27, 2023

Comments are closed.

Latest News

Investigating the Connection Between Steps and Heart Disease Risk

Feb 1, 2023

Medical School Faculty Named AAAS Fellows

Jan 31, 2023

Transforming the Way Cancer Vaccines are Designed and Made

Jan 30, 2023

Calcium Channels Regulate Neuroinflammation and Neuropathic Pain 

Jan 27, 2023

Changes in Medical School Leadership

Jan 26, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
Feinberg_In_Vivo_20221209_tcrawford-24
Feinberg_In_Vivo_20221209_tcrawford-16
Feinberg_In_Vivo_20221209_tcrawford-14
Feinberg_In_Vivo_20221209_tcrawford-5
Feinberg_In_Vivo_20221209_tcrawford-6
Feinberg_In_Vivo_20221209_tcrawford-10
Feinberg_In_Vivo_20221209_tcrawford-8
Feinberg_In_Vivo_20221209_tcrawford-18
Feinberg_In_Vivo_20221209_tcrawford
Feinberg_In_Vivo_20221209_tcrawford-23
Feinberg_In_Vivo_20221209_tcrawford-25
Feinberg_In_Vivo_20221209_tcrawford-26

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.